9875 related articles for article (PubMed ID: 12650602)
21. Expression of KISS1 and KISS1R (GPR54) may be used as favorable prognostic markers for patients with non-small cell lung cancer.
Sun YB; Xu S
Int J Oncol; 2013 Aug; 43(2):521-30. PubMed ID: 23716269
[TBL] [Abstract][Full Text] [Related]
22. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N
Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099
[TBL] [Abstract][Full Text] [Related]
23. Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis.
Welch DR; Steeg PS; Rinker-Schaeffer CW
Breast Cancer Res; 2000; 2(6):408-16. PubMed ID: 11250734
[TBL] [Abstract][Full Text] [Related]
24. KiSS1 in regulation of metastasis and response to antitumor drugs.
Corno C; Perego P
Drug Resist Updat; 2019 Jan; 42():12-21. PubMed ID: 30776659
[TBL] [Abstract][Full Text] [Related]
25. Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP.
Goldberg SF; Miele ME; Hatta N; Takata M; Paquette-Straub C; Freedman LP; Welch DR
Cancer Res; 2003 Jan; 63(2):432-40. PubMed ID: 12543799
[TBL] [Abstract][Full Text] [Related]
26. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases.
Stark AM; Tongers K; Maass N; Mehdorn HM; Held-Feindt J
J Cancer Res Clin Oncol; 2005 Mar; 131(3):191-8. PubMed ID: 15592684
[TBL] [Abstract][Full Text] [Related]
27. KISS1 in breast cancer progression and autophagy.
Ulasov IV; Borovjagin AV; Timashev P; Cristofanili M; Welch DR
Cancer Metastasis Rev; 2019 Sep; 38(3):493-506. PubMed ID: 31705228
[TBL] [Abstract][Full Text] [Related]
28. KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha.
Jiang Y; Berk M; Singh LS; Tan H; Yin L; Powell CT; Xu Y
Clin Exp Metastasis; 2005; 22(5):369-76. PubMed ID: 16283480
[TBL] [Abstract][Full Text] [Related]
29. KiSS1-induced GPR54 signaling inhibits breast cancer cell migration and epithelial-mesenchymal transition via protein kinase D1.
Tan K; Cho SG; Luo W; Yi T; Wu X; Siwko S; Liu M; Yuan W
Curr Mol Med; 2014; 14(5):652-62. PubMed ID: 24894166
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of mouse metastasis-suppressor KiSS1 and its G-protein-coupled receptor.
Stafford LJ; Xia C; Ma W; Cai Y; Liu M
Cancer Res; 2002 Oct; 62(19):5399-404. PubMed ID: 12359743
[TBL] [Abstract][Full Text] [Related]
31. KiSS1 gene as a novel mediator of TGFβ-mediated cell invasion in triple negative breast cancer.
Tian J; Al-Odaini AA; Wang Y; Korah J; Dai M; Xiao L; Ali S; Lebrun JJ
Cell Signal; 2018 Jan; 42():1-10. PubMed ID: 28988968
[TBL] [Abstract][Full Text] [Related]
32. The kisspeptin (KiSS-1)/GPR54 system in cancer biology.
Makri A; Pissimissis N; Lembessis P; Polychronakos C; Koutsilieris M
Cancer Treat Rev; 2008 Dec; 34(8):682-92. PubMed ID: 18583061
[TBL] [Abstract][Full Text] [Related]
33. Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23.
Shirasaki F; Takata M; Hatta N; Takehara K
Cancer Res; 2001 Oct; 61(20):7422-5. PubMed ID: 11606374
[TBL] [Abstract][Full Text] [Related]
34. Intracellular signaling pathways activated by kisspeptins through GPR54: do multiple signals underlie function diversity?
Castaño JP; Martínez-Fuentes AJ; Gutiérrez-Pascual E; Vaudry H; Tena-Sempere M; Malagón MM
Peptides; 2009 Jan; 30(1):10-5. PubMed ID: 18775460
[TBL] [Abstract][Full Text] [Related]
35. Kisspeptin/GPR54 system as potential target for endocrine disruption of reproductive development and function.
Tena-Sempere M
Int J Androl; 2010 Apr; 33(2):360-8. PubMed ID: 19906185
[TBL] [Abstract][Full Text] [Related]
36. KISS1 in metastatic cancer research and treatment: potential and paradoxes.
Ly T; Harihar S; Welch DR
Cancer Metastasis Rev; 2020 Sep; 39(3):739-754. PubMed ID: 32152912
[TBL] [Abstract][Full Text] [Related]
37. Expression of Kisspeptin (KISS1) and its Receptor GPR54 (KISS1R) in Prostate Cancer.
Xoxakos I; Petraki C; Msaouel P; Armakolas A; Grigorakis A; Stefanakis S; Koutsilieris M
Anticancer Res; 2020 Feb; 40(2):709-718. PubMed ID: 32014912
[TBL] [Abstract][Full Text] [Related]
38. A role for kisspeptins in pregnancy: facts and speculations.
Reynolds RM; Logie JJ; Roseweir AK; McKnight AJ; Millar RP
Reproduction; 2009 Jul; 138(1):1-7. PubMed ID: 19336473
[TBL] [Abstract][Full Text] [Related]
39. Kiss1-/- mice exhibit more variable hypogonadism than Gpr54-/- mice.
Lapatto R; Pallais JC; Zhang D; Chan YM; Mahan A; Cerrato F; Le WW; Hoffman GE; Seminara SB
Endocrinology; 2007 Oct; 148(10):4927-36. PubMed ID: 17595229
[TBL] [Abstract][Full Text] [Related]
40. A twisted kiss: in vitro and in vivo evidence of genetic variation and suppressed transcription of the metastasis-suppressor gene KiSS1 in early breast cancer.
Pentheroudakis G; Kostadima L; Dova L; Georgiou I; Tzavaras T; Vartholomatos G; Wirtz RM; Fountzilas G; Malamou-Mitsi V; Pavlidis N
Neoplasma; 2010; 57(1):47-54. PubMed ID: 19895172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
